tetano
Editor, Senior Moderator
Biol Sex Differ
. 2021 Feb 5;12(1):20.
doi: 10.1186/s13293-021-00359-2.
Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans
Yilin Yoshida[SUP] 1 2 [/SUP], Scott A Gillet[SUP] 3 [/SUP], Margo I Brown[SUP] 3 [/SUP], Yuanhao Zu[SUP] 4 [/SUP], Sarah M Wilson[SUP] 1 2 [/SUP], Sabreen J Ahmed[SUP] 1 2 [/SUP], Saritha Tirumalasetty[SUP] 1 2 [/SUP], Dragana Lovre[SUP] 1 2 [/SUP], Marie Krousel-Wood[SUP] 3 5 [/SUP], Joshua L Denson[SUP] 6 [/SUP], Franck Mauvais-Jarvis[SUP] 7 8 [/SUP]
Affiliations
Abstract
Objectives: Determine if sex differences exist in clinical characteristics and outcomes of adults hospitalized for coronavirus disease 2019 (COVID-19) in a US healthcare system.
Design: Case series study.
Setting and participants: Sequentially hospitalized adults admitted for COVID-19 at two tertiary care academic hospitals in New Orleans, LA, between 27 February and 15 July 2020.
Measures and outcomes: Measures included demographics, comorbidities, presenting symptoms, and laboratory results. Outcomes included intensive care unit admission (ICU), invasive mechanical ventilation (IMV), and in-hospital death.
Results: We included 776 patients (median age 60.5 years; 61.4% women, 75% non-Hispanic Black). Rates of ICU, IMV, and death were similar in both sexes. In women versus men, obesity (63.8 vs 41.6%, P < 0.0001), hypertension (77.6 vs 70.1%, P = 0.02), diabetes (38.2 vs 31.8%, P = 0.06), chronic obstructive pulmonary disease (COPD, 22.1 vs 15.1%, P = 0.015), and asthma (14.3 vs 6.9%, P = 0.001) were more prevalent. More women exhibited dyspnea (61.2 vs 53.7%, P = 0.04), fatigue (35.7 vs 28.5%, P = 0.03), and digestive symptoms (39.3 vs 32.8%, P = 0.06) than men. Obesity was associated with IMV at a lower BMI (> 35) in women, but the magnitude of the effect of morbid obesity (BMI ≥ 40) was similar in both sexes. COPD was associated with ICU (adjusted OR (aOR), 2.6; 95%CI, 1.5-4.3) and IMV (aOR, 1.8; 95%CI, 1.2-3.1) in women only. Diabetes (aOR, 2.6; 95%CI, 1.2-2.9), chronic kidney disease (aOR, 2.2; 95%CI, 1.3-5.2), elevated neutrophil-to-lymphocyte ratio (aOR, 2.5; 95%CI, 1.4-4.3), and elevated ferritin (aOR, 3.6; 95%CI, 1.7-7.3) were independent predictors of death in women only. In contrast, elevated D-dimer was an independent predictor of ICU (aOR, 7.3; 95%CI, 2.7-19.5), IMV (aOR, 6.5; 95%CI, 2.1-20.4), and death (aOR, 4.5; 95%CI, 1.2-16.4) in men only.
Conclusions: This study highlights sex disparities in clinical determinants of severe outcomes in COVID-19 patients that may inform management and prevention strategies to ensure gender equity.
. 2021 Feb 5;12(1):20.
doi: 10.1186/s13293-021-00359-2.
Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans
Yilin Yoshida[SUP] 1 2 [/SUP], Scott A Gillet[SUP] 3 [/SUP], Margo I Brown[SUP] 3 [/SUP], Yuanhao Zu[SUP] 4 [/SUP], Sarah M Wilson[SUP] 1 2 [/SUP], Sabreen J Ahmed[SUP] 1 2 [/SUP], Saritha Tirumalasetty[SUP] 1 2 [/SUP], Dragana Lovre[SUP] 1 2 [/SUP], Marie Krousel-Wood[SUP] 3 5 [/SUP], Joshua L Denson[SUP] 6 [/SUP], Franck Mauvais-Jarvis[SUP] 7 8 [/SUP]
Affiliations
- PMID: 33546750
- DOI: 10.1186/s13293-021-00359-2
Abstract
Objectives: Determine if sex differences exist in clinical characteristics and outcomes of adults hospitalized for coronavirus disease 2019 (COVID-19) in a US healthcare system.
Design: Case series study.
Setting and participants: Sequentially hospitalized adults admitted for COVID-19 at two tertiary care academic hospitals in New Orleans, LA, between 27 February and 15 July 2020.
Measures and outcomes: Measures included demographics, comorbidities, presenting symptoms, and laboratory results. Outcomes included intensive care unit admission (ICU), invasive mechanical ventilation (IMV), and in-hospital death.
Results: We included 776 patients (median age 60.5 years; 61.4% women, 75% non-Hispanic Black). Rates of ICU, IMV, and death were similar in both sexes. In women versus men, obesity (63.8 vs 41.6%, P < 0.0001), hypertension (77.6 vs 70.1%, P = 0.02), diabetes (38.2 vs 31.8%, P = 0.06), chronic obstructive pulmonary disease (COPD, 22.1 vs 15.1%, P = 0.015), and asthma (14.3 vs 6.9%, P = 0.001) were more prevalent. More women exhibited dyspnea (61.2 vs 53.7%, P = 0.04), fatigue (35.7 vs 28.5%, P = 0.03), and digestive symptoms (39.3 vs 32.8%, P = 0.06) than men. Obesity was associated with IMV at a lower BMI (> 35) in women, but the magnitude of the effect of morbid obesity (BMI ≥ 40) was similar in both sexes. COPD was associated with ICU (adjusted OR (aOR), 2.6; 95%CI, 1.5-4.3) and IMV (aOR, 1.8; 95%CI, 1.2-3.1) in women only. Diabetes (aOR, 2.6; 95%CI, 1.2-2.9), chronic kidney disease (aOR, 2.2; 95%CI, 1.3-5.2), elevated neutrophil-to-lymphocyte ratio (aOR, 2.5; 95%CI, 1.4-4.3), and elevated ferritin (aOR, 3.6; 95%CI, 1.7-7.3) were independent predictors of death in women only. In contrast, elevated D-dimer was an independent predictor of ICU (aOR, 7.3; 95%CI, 2.7-19.5), IMV (aOR, 6.5; 95%CI, 2.1-20.4), and death (aOR, 4.5; 95%CI, 1.2-16.4) in men only.
Conclusions: This study highlights sex disparities in clinical determinants of severe outcomes in COVID-19 patients that may inform management and prevention strategies to ensure gender equity.